A new vaccine against the
Staphylococcus aureus 'superbacterium' has been found to work in
mice, the journal of the United States National Academy of
Sciences (NAS) reported Monday.
S. aureus is a common cause of skin infections, respiratory
disease, and food poisoning, and the emergence of
antibiotic-resistant forms has become a worldwide problem in
clinical medicine.
The research at a center run by Swiss pharmaceuticals
giant Novartis in the city of Siena is led by world-renowned
scientist Rino Rappuoli, a pioneer in the field of vaccines and
immunology.
Rappuoli and his team have developed a vaccine made up of
five antigens, or antibody generators, which has proven
effective in lab mice.
ALL RIGHTS RESERVED © Copyright ANSA
